Rani Therapeutics Holdings, Inc. Class A Common Stock
1.16
USD
+0.01
+0.43%
Apr 17, 15:53 UTC -4
Closed
After-Market
1.23
+0.07
+6.15%
Rani Therapeutics Holdings, Inc. Class A Common Stock Profile
About
Rani Therapeutics Holdings Inc. is a clinical stage biotherapeutics company. It focused on advancing technologies to enable the development of orally administered biologics. Rani Therapeutics Holdings Inc. is based in SAN JOSE, Calif.
Info & Links
CEO
Talat Imran
Headquarters
2051 RINGWOOD AVENUE SAN JOSE, CA 95131, UNITED STATES
Rani Therapeutics Holdings, Inc. Class A Common Stock Statistics
Valuation Measures
Market Capitalization2
41.08M
Enterprise Value
61.93M
Enterprise Value/EBITDA(ttm)
-1.14
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
16.15
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
0.00%
Operating Margin(ttm)
--
Profit Margin(ttm)
0.00%
Return on Equity(ttm)
-219.64%
Return on Invested Capital(ttm)
-286.31%
Return on Assets(ttm)
-56.71%
Income Statement
Revenue(ttm)
0.00
Revenue Per Share(ttm)
0.00
Gross Profit(ttm)
0.00
EBITDA(ttm)3
-54.33M
Net Income Available to Common(ttm)
-30.02M
Diluted EPS(ttm)
-1.06
Share Statistics
Beta (5Y Monthly)
0.16
52-Week Change
-85.29%
S&P 500 52-Week Change
6.35%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
57.48M
Dividend Yield
0.00%
Float4
26.75M
% Held by Insiders
53.30%
% Held by Institutions
30.19%
Balance Sheet
Total Cash(mrq)
27.64M
Total Cash Per Share(mrq)
0.48
Total Debt(mrq)
24.61M
Total Debt/Equity(mrq)
704.64%
Current Ratio(mrq)
1.50%
Quick Ratio(mrq)
1.60%
Book Value Per Share(mrq)
0.06
Cash Flow
Operating Cash Flow Per Share(ytd)
-1.25
Free Cash Flow(ytd)
-35.76M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.